Adia Med ADIA
OTC ADIA
$0.13 +0.01 (+8.33%)
At close: Nov 10, 2026 · 4:00 PM EST

Adia Med (ADIA) Return on Sales [ROS] (2025 - 2026)

Updated

Adia Nutrition (ADIA) posted Return on Sales [ROS] of -86.18% for Q1 2026, up 67.85 percentage points from -154.04% a year earlier.

Analysis

Adia Med (ADIA) Return on Sales [ROS] (2025 - 2026) Analysis & Trends

For FY2025, Adia Nutrition's Return on Sales [ROS] came in at -52.32%, up 2686.69 percentage points from FY2024.

  • In prior years, Adia Nutrition's Return on Sales [ROS] was -2739.01% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Adia Med 12.27 Mn 11.92 Mn 282,580.00 10.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.68%
Mar 31, 2026 -86.18%
Jun 30, 2025 -98.68%
Mar 31, 2025 -154.04%
API Access

Adia Med Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ADIA&period=max&api_key=YOUR_API_KEY